Remove GlobalData Healthcare
article thumbnail

Digital health tech: a solution to substance use disorders?

Pharmaceutical Technology

Healthcare providers are under pressure to address the growing issue of substance use disorders. A recent study in the Journal of the American Medical Association found that between 2015 and 2019 as high as one in eight deaths in the US could be attributable to excessive alcohol consumption.

article thumbnail

Digital clinical trials: Trends to watch in 2023

Pharmaceutical Technology

Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

Partly in response to such drugs, risk-sharing agreements (RSAs) have increased in popularity and aim to mitigate the risks of including high-cost drugs on reimbursement lists and healthcare plans. GlobalData takes this opportunity to review the various types of RSAs and their evolution over time.

Marketing 105
article thumbnail

Lupkynis approved for the treatment of LN in the EU and UK

Pharmaceutical Technology

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has also since granted the Great Britain marketing authorisation of Lupkynis to treat adults with active LN. Notably, Lupkynis is the first oral therapy approved by the US Food and Drug Administration (FDA) and EC for the treatment of active LN.

article thumbnail

Worldwide healthtech growth: how the UK and Scotland are positioned

Pharmaceutical Technology

Technology is advancing the possibilities of healthcare treatments, from the development of innovative new drugs to freeing up time for doctors thanks to monitoring devices for patients with conditions such as diabetes and high blood pressure. between 2017 and 2021, peaking at 453 deals in 2020, according to GlobalData figures.

article thumbnail

Economic unrest results in an average pharmaceutical price trend of 1,123% in Lebanon

Pharmaceutical Technology

In Lebanon, the battle for access to medicines rages on and is further heightened by dramatic decreases to the healthcare budget last year. GlobalData reviews the key events leading up to these current price trends in Lebanon. Consequentially, the five-year average price trend in Lebanon for all medicines has increased to 1,123%.

article thumbnail

2022 in Review: Tracking the ups and downs of pharma deals

Pharmaceutical Technology

Further analysis shows that the appetite for large acquisitions seen in 2018 and 2019 has not returned after the pandemic. “[We] With data analysis support from GlobalData analyst Ophelia Chan. It will just take a matter of time before things get back to normality.”.

Pharma 52